1. Which of the following is considered a critical factor in sterile
compounding that ensures the protection of patient health?
A. The speed of drug preparation
B. The sterility of compounded drugs
C. The appearance of the preparation
D. The cost of the compounded preparation
Answer: B) The sterility of compounded drugs
Rationale: The sterility of compounded preparations is the most
critical factor, as it directly impacts patient safety and health by
preventing infections and other complications.
2. Which of the following is a potential risk associated with
improper garbing before sterile compounding?
A. Increased contamination in the preparation area
B. Faster drug preparation
C. Decreased equipment maintenance costs
D. Improved drug solubility
Answer: A) Increased contamination in the preparation area
Rationale: Improper garbing can lead to the introduction of
contaminants into the sterile compounding environment,
increasing the risk of microbial or particulate contamination.
,3. How should personnel handle compounded sterile preparations
that need to be delivered to patients?
A. By placing them in regular shipping boxes
B. By using containers that maintain sterility and proper
temperature
C. By carrying them openly without any cover
D. By storing them in non-sterile plastic bags
Answer: B) By using containers that maintain sterility and proper
temperature
Rationale: Sterile preparations should be transported in containers
that maintain their sterility and temperature to ensure they are
safe for patient use.
4. Which type of compounding should be performed in an ISO 5
environment with Class 100 air quality?
A. Medium- and high-risk compounding
B. Low-risk compounding
C. Non-sterile compounding
D. Compounding for oral preparations only
Answer: A) Medium- and high-risk compounding
Rationale: Compounding activities involving medium- and high-
risk preparations must occur in an ISO 5 environment, which
provides the necessary air quality for sterility assurance.
, 5. How should a pharmacist address a situation where a
compounded sterile preparation (CSP) has an incorrect label or is
missing necessary information?
A. Ignore the issue and dispense the preparation
B. Discard the preparation and prepare a new one with correct
labeling
C. Ask the patient to fill out the missing information
D. Submit the preparation to testing
Answer: B) Discard the preparation and prepare a new one with
correct labeling
Rationale: Proper labeling is essential for patient safety, and any
CSP with incorrect or missing labeling should be discarded and
re-prepared with the correct information.
6. How should compounded sterile preparations be disposed of if
they have been contaminated during preparation?
A. By placing them in regular waste bins
B. By using a specialized hazardous waste container
C. By returning them to the manufacturer
D. By disposing of them in the nearest sink
Answer: B) By using a specialized hazardous waste container
compounding that ensures the protection of patient health?
A. The speed of drug preparation
B. The sterility of compounded drugs
C. The appearance of the preparation
D. The cost of the compounded preparation
Answer: B) The sterility of compounded drugs
Rationale: The sterility of compounded preparations is the most
critical factor, as it directly impacts patient safety and health by
preventing infections and other complications.
2. Which of the following is a potential risk associated with
improper garbing before sterile compounding?
A. Increased contamination in the preparation area
B. Faster drug preparation
C. Decreased equipment maintenance costs
D. Improved drug solubility
Answer: A) Increased contamination in the preparation area
Rationale: Improper garbing can lead to the introduction of
contaminants into the sterile compounding environment,
increasing the risk of microbial or particulate contamination.
,3. How should personnel handle compounded sterile preparations
that need to be delivered to patients?
A. By placing them in regular shipping boxes
B. By using containers that maintain sterility and proper
temperature
C. By carrying them openly without any cover
D. By storing them in non-sterile plastic bags
Answer: B) By using containers that maintain sterility and proper
temperature
Rationale: Sterile preparations should be transported in containers
that maintain their sterility and temperature to ensure they are
safe for patient use.
4. Which type of compounding should be performed in an ISO 5
environment with Class 100 air quality?
A. Medium- and high-risk compounding
B. Low-risk compounding
C. Non-sterile compounding
D. Compounding for oral preparations only
Answer: A) Medium- and high-risk compounding
Rationale: Compounding activities involving medium- and high-
risk preparations must occur in an ISO 5 environment, which
provides the necessary air quality for sterility assurance.
, 5. How should a pharmacist address a situation where a
compounded sterile preparation (CSP) has an incorrect label or is
missing necessary information?
A. Ignore the issue and dispense the preparation
B. Discard the preparation and prepare a new one with correct
labeling
C. Ask the patient to fill out the missing information
D. Submit the preparation to testing
Answer: B) Discard the preparation and prepare a new one with
correct labeling
Rationale: Proper labeling is essential for patient safety, and any
CSP with incorrect or missing labeling should be discarded and
re-prepared with the correct information.
6. How should compounded sterile preparations be disposed of if
they have been contaminated during preparation?
A. By placing them in regular waste bins
B. By using a specialized hazardous waste container
C. By returning them to the manufacturer
D. By disposing of them in the nearest sink
Answer: B) By using a specialized hazardous waste container
